Source: ERS Lung Science Conference 2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Thomas Marichal (Liège, Belgium). Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation. ERS Lung Science Conference 2019

Member's Comments

No comment yet.

Related content which might interest you: Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Autoimmunity  in airway inflammation and asthma Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017 Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model Source: ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017 Year: 2017 Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production in vitro and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma in vivo Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013 Levofloxacin prevents eosinophil activation and asthma exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 207s Year: 2006 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Cytokine regulation of the chronicle inflammation of bronchial asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 590s Year: 2005 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Role of neutrophils in maintenance of severity of non-allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007 Extracellular nucleotides contribute to the pathogenesis of viral-induced exacerbations in COPD via P2X4/P2X7-receptor activation Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 The abnormalities in spontaneous and Fas-induced apoptosis in atopic bronchial asthma (ABA): the key to chronic lung inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 228s Year: 2006